Sublimity Therapeutics, an Irish pharmaceutical in the realm of gastrointestinal and immunological diseases, has set up a Solana Beach office with six employees.
Plans ultimately call for a dozen workers in the Solana Beach space, including key executives, focused on clinical operations. San Diego’s talent pool fit the bill for company needs in this area, according to Sublimity.
Recently Sublimity raised $64 million to advance its lead program, STI-0529, for treatment of ulcerative colitis. The company is based in Dublin, Ireland.
San Diego-based Arena Pharmaceuticals is also working on an ulcerative colitis drug, as is Receptos, purchased by Celgene in 2015.